Scinai Immunotherapeutics (SCNI) Stock Chart & Stock Price History $2.54 -0.04 (-1.55%) Closing price 03:56 PM EasternExtended Trading$2.64 +0.10 (+4.09%) As of 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Scinai Immunotherapeutics (SCNI) Stock Price Performance 5 Day Performance-10.69%1 Month Performance+29.59%3 Month Performance-23.49%Year-To-Date Performance-24.18%1 Year Performance-45.96% SCNI Stock Chart for Monday, May, 12, 2025 SCNI Chart by TradingView The Scinai Immunotherapeutics (SCNI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 45.96%, with a year-to-date return of -24.18%. In the past month, the stock has increased 29.59%, reflecting recent market activity. As of the latest close, Scinai Immunotherapeutics traded at $2.58 with a market cap of $2.41 million and volume of 6,406 shares. Receive SCNI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Scinai Immunotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Scinai Immunotherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/12/2025$2.58$2.54-1.55%$2.65$2.5310,535 shs$2.37 million05/09/2025$2.80$2.58-7.86%$2.84$2.586,406 shs$2.41 million05/08/2025$2.84$2.80-1.55%$2.94$2.762,799 shs$2.62 million05/07/2025$2.85$2.84-0.21%$2.85$2.801,116 shs$2.66 million05/06/2025$2.78$2.85+2.48%$2.90$2.647,769 shs$2.66 million05/05/2025$2.79$2.78-0.18%$2.90$2.6711,737 shs$2.60 million05/02/2025$2.83$2.79-1.42%$2.88$2.738,055 shs$2.60 million05/01/2025$2.64$2.83+7.05%$2.78$2.5610,989 shs$2.64 million04/30/2025$2.61$2.64+1.15%$2.72$2.52118,613 shs$2.47 million04/29/2025$2.46$2.61+6.31%$2.63$2.2350,013 shs$2.44 million Get the Latest News and Ratings for SCNI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Scinai Immunotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/28/2025$2.51$2.46-2.19%$2.59$2.405,578 shs$2.29 million04/25/2025$2.42$2.51+3.72%$2.69$2.511,219 shs$2.34 million04/24/2025$2.42$2.42$2.54$2.2210,513 shs$2.26 million04/23/2025$2.15$2.42+12.56%$2.54$2.1917,878 shs$2.26 million04/22/2025$2.10$2.15+2.63%$2.19$2.089,059 shs$2.01 million04/21/2025$2.01$2.10+4.23%$2.15$2.055,206 shs$1.96 million04/18/2025$2.01$2.01$2.15$1.9816,620 shs$1.88 million04/17/2025$1.92$2.01+4.69%$2.15$1.9816,620 shs$1.88 million04/16/2025$1.92$1.92$2.10$1.9119,367 shs$1.79 million04/15/2025$2.00$1.92-4.00%$1.98$1.907,744 shs$1.79 million04/14/2025$1.96$2.00+2.04%$2.03$1.9319,097 shs$1.87 million04/11/2025$2.20$1.96-10.91%$2.39$1.9353,579 shs$1.83 million Related Companies PHAXIAM Therapeutics Stock Price Chart Kiora Pharmaceuticals Stock Price Chart Sensei Biotherapeutics Stock Price Chart Athira Pharma Stock Price Chart Cyclerion Therapeutics Stock Price Chart Aprea Therapeutics Stock Price Chart Carisma Therapeutics Stock Price Chart Talphera Stock Price Chart Portage Biotech Stock Price Chart Neuphoria Therapeutics Inc. - Common Stock Stock Price Chart Receive SCNI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Scinai Immunotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SCNI) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredElon Musk’s Next Big BetCancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scinai Immunotherapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scinai Immunotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
